ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii.
| Image |  |
|---|---|
| Description | scientific article published on 30 June 2017 |
| Author/s |
author: Adam B Shapiro Samir H Moussa |
| Publication date | June 30, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |